scorecardresearch
Magazine
Clear all

Stock Analysis

View More

LATEST NEWS

View More
    News
    Markets
    Stocks
    Aurobindo Pharma Ltd

    Feedback
    Aurobindo Pharma Ltd

    Aurobindo Pharma Ltd (AUROPHARMA) Share Price

    • Sector: Pharmaceuticals (Mid Cap)
    • Volume: 317,069
    Aug 08, 2023 10:00 IST-
    • NSE
    • BSE
    • Share
      • Whatsapp
      • Twitter
      • Facebook
    ₹867.75
    ₹0.50 (0.01%)
    ₹865.5 Low
    Today’s Performance
    ₹875 High
    ₹397.2 Low
    52 Week’s Performance
    ₹875 High

    STOCK ANALYSIS

    STOCK PERFORMANCE

    • 1 Day -0.06%
    • 1 Week 5.59%
    • 1 Month 16.45%
    • 3 Months 40.28%
    • 6 Months 107.39%
    • 1 Year 52.90%
    • 3 Years -1.42%
    • 5 Years 6.99%

    PEER COMPARISON

    STOCK SUMMARY

    • Face Value (₹) 1.00
    • Beta 0.61
    • 52-Week Low (₹) 397.20
    • 52-Week High (₹) 874.30
    • Price-to-Book (X)* 1.89
    • Dividend Yield (%) 0.86
    • Price-to-Earnings (P/E) (X)* 26.49
    • Earnings Per Share (₹) 32.76
    • Sector Price Earning (X)* 33.50
    • Market Cap (₹ Cr.)* 50,874.12
    • * Vaues as of last close price

    COMPETITORS

    BT TV

    Thumb 3:45 Centre Says Complex Conspiracy To Push Chinese Propaganda
    Thumb 3:25 Citroen C3 Aircross: A Stylish And Basic Feature-Packed Mid-Size SUV
    Thumb 18:01 India's FinTech Space Has Made Remarkable Strides, Says Red Hat's Stefanie Chiras
    thumb 12:01 Thoughtworks Retail Rendezvous: Commerce Platforms, Marketplaces & Marketplaces Evolution
    thumb 11:04 Thoughtworks Retail Rendezvous: Commerce Platforms, Marketplaces & Marketplaces Evolution
    View more

    FINANCIAL ANALYSIS

    Income Statement (₹ Cr.)
    Balance Sheet (₹ Cr.)
    Cash Flow (₹ Cr.)
    Income Statement (₹ Cr.)
    Balance Sheet (₹ Cr.)
    Cash Flow (₹ Cr.)

    RATIO ANALYSIS

    Return on Equity (%)
    Return on Assets (%)
    Price-to-Earnings (P/E) (X)
    Price to Book (x)
    Return on Capital Employed (%)
    Enterprise Value to EBITDA (X)
    Net Profit Margin (%)
    Gross Profit Margin (%)
    EBITDA Margin (%)
    Return on Equity (%)
    Return on Assets (%)
    Price-to-Earnings (P/E) (X)
    Price to Book (x)
    Return on Capital Employed (%)
    Enterprise Value to EBITDA (X)
    Net Profit Margin (%)
    Gross Profit Margin (%)
    EBITDA Margin (%)

    SHAREHOLDING PATTERN

    Summary (as on 30 sep 2022)

    DEALS

    Mar 11, 2022 Sell
    Aurobindo Pharma Ltd ,PZENA VALUE FUNDS PLC/PZENA EMERGING MARKETS VALUE FUND
    • Qty 250294
    • Average Price ₹630.40
    Mar 11, 2022 PURCHASE
    Aurobindo Pharma Ltd ,PZENA VALUE FUNDS PLC/PZENA EMERGING MARKETS VALUE FUND
    • Qty 250294
    • Average Price ₹630.40
    Aug 08, 2022 Sell
    Aurobindo Pharma Ltd. ,ISHARES INDIA INDEX MAURITIUS COMPANY
    • Qty 311433
    • Average Price ₹568.65
    Aug 08, 2022 PURCHASE
    Aurobindo Pharma Ltd. ,ISHARES MSCI INDIA ETF
    • Qty 311433
    • Average Price ₹568.65
    Nov 03, 2022 Sell
    Aurobindo Pharma Ltd. ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
    • Qty 297309
    • Average Price ₹557.30
    Nov 03, 2022 PURCHASE
    Aurobindo Pharma Ltd. ,ISHARES CORE MSCI EMERGING MARKETS ETF
    • Qty 297309
    • Average Price ₹557.30
    Nov 14, 2022 Sell
    Aurobindo Pharma Ltd. ,ISHARES CORE EMERGING MARKETS MAURITIUS CO
    • Qty 297308
    • Average Price ₹489.30
    Nov 14, 2022 PURCHASE
    Aurobindo Pharma Ltd. ,ISHARES CORE MSCI EMERGING MARKETS ETF
    • Qty 297308
    • Average Price ₹489.30
    May 04, 2022 Sell
    AUROPHARMA ,ISHARES CORE TOTAL INTERNATIONAL STOCK MAURITIUS CO
    • Qty 354384
    • Average Price ₹642.50
    May 04, 2022 PURCHASE
    AUROPHARMA ,ISHARES CORE MSCI TOTAL INTERNATIONAL STOCK ETF
    • Qty 354384
    • Average Price ₹642.50
    *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
    Oct 07, 2016 Sell
    Aurobindo Pharma Ltd. ,SUNEELA RANI PENAKA
    • Qty 8660510
    • Average Price ₹849.30
    May 30, 2014 Sell
    Aurobindo Pharma Ltd. ,M/S MORGAN STANLEY ASIA SINGAPORE PTE
    • Qty 1732500
    • Average Price ₹669.92
    May 30, 2014 PURCHASE
    Aurobindo Pharma Ltd. ,ABU DHABI INVESTMENT AUTHORUTY - GULAB
    • Qty 1475687
    • Average Price ₹670.51
    Sep 19, 2014 PURCHASE
    Aurobindo Pharma Ltd. ,THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE
    • Qty 2360231
    • Average Price ₹875.94
    Aug 29, 2013 Sell
    Aurobindo Pharma Ltd. ,MACQUARIE BANK LIMITED
    • Qty 1940000
    • Average Price ₹180.97
    Oct 07, 2016 Sell
    Aurobindo Pharma Ltd. ,SUNEELA RANI PENAKA
    • Qty 8660510
    • Average Price ₹849.30
    May 30, 2014 Sell
    Aurobindo Pharma Ltd. ,M/S MORGAN STANLEY ASIA SINGAPORE PTE
    • Qty 1732500
    • Average Price ₹669.92
    May 30, 2014 PURCHASE
    Aurobindo Pharma Ltd. ,ABU DHABI INVESTMENT AUTHORUTY - GULAB
    • Qty 1475687
    • Average Price ₹670.51
    Sep 19, 2014 PURCHASE
    Aurobindo Pharma Ltd. ,THE VANGUARD GROUP INC A/C VANGUARD EMERG. MKTS STOCK INDE
    • Qty 2360231
    • Average Price ₹875.94
    Aug 29, 2013 Sell
    Aurobindo Pharma Ltd. ,MACQUARIE BANK LIMITED
    • Qty 1940000
    • Average Price ₹180.97
    *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

    FAQ’S

    What was Aurobindo Pharma Ltd share price previously?
    Aurobindo Pharma Ltd share price was down by -0.01% from the previous closing price of ₹868.25.
    Who are peers of Aurobindo Pharma Ltd?
    The peers of Aurobindo Pharma Ltd are Divis Laboratories Ltd, Lupin Ltd, Ipca Laboratories Ltd, Glaxosmithkline Pharmaceuticals Ltd, Alkem Laboratories Ltd, Syngene International Ltd, Biocon Ltd, Torrent Pharmaceuticals Ltd, Glenmark Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Ajanta Pharma Ltd, Dr Reddys Laboratories Ltd.
    Who is/are the promoter/promoters of Aurobindo Pharma Ltd?
    The promotor/promotors of Aurobindo Pharma Ltd are P V Ramprasad Reddy, K Nithyananda Reddy, M Sivakumaran, M Madan Mohan Reddy, P Sarath Chandra Reddy, K Ragunathan, Avnit Bimal Singh, B Adi Reddy, Savita Mahajan, Girish Paman Vanvari, Santanu Mukherjee.
    What has been 52-week high of Aurobindo Pharma Ltd stocks?
    The highest price of Aurobindo Pharma Ltd stock is ₹874.30 in the last 52-week.
    What is the share price of Aurobindo Pharma Ltd (AUROPHARMA) today on NSE?
    As on Aug 08, 2023, Aurobindo Pharma Ltd (AUROPHARMA)’s share price on NSE is Rs 867.75
    What is the market cap of Aurobindo Pharma Ltd (AUROPHARMA?)
    The current market capitalisation of Aurobindo Pharma Ltd (AUROPHARMA) is 50,874.12 crores
    What is Aurobindo Pharma Ltd Share symbol?
    The symbol of Aurobindo Pharma Ltd is AUROPHARMA.
    What is the PE ratio of Aurobindo Pharma Ltd (AUROPHARMA)?
    The current PE ratio of Aurobindo Pharma Ltd (AUROPHARMA) is 26.49.
    What is the PB ratio of Aurobindo Pharma Ltd (AUROPHARMA)?
    The current PB ratio of Aurobindo Pharma Ltd (AUROPHARMA) is 1.89.
    Today’s High & Low share prices of Aurobindo Pharma Ltd (AUROPHARMA) on NSE?
    Today, the share price of Aurobindo Pharma Ltd (AUROPHARMA) on NSE touched a high of Rs 875 and a low of Rs 865.5
    What price did Aurobindo Pharma Ltd (AUROPHARMA) shares open on the NSE today?
    On NSE, the share price of Aurobindo Pharma Ltd (AUROPHARMA) opened at Rs 870
    What is the 52-week high of Aurobindo Pharma Ltd (AUROPHARMA)?
    The 52-week high price of Aurobindo Pharma Ltd (AUROPHARMA) is Rs 875
    What is the 52-week low of Aurobindo Pharma Ltd (AUROPHARMA) ?
    The 52-week low price of Aurobindo Pharma Ltd (AUROPHARMA) is Rs 397.2

    ABOUT AUROBINDO PHARMA

    Aurobindo Pharma Ltd, incorporated in the year 1986, has its registered office in Plot No 2 Maitrivihar, Behind Maithri Vanam Ameerpet, Hyderabad, Telangana, 500038, 91-40-23736370, 91-40-23747340. The main industry in which Aurobindo Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

    Auditor/Auditors for Aurobindo Pharma Ltd is/are Deloitte Haskins & Sells. In the main management, K Ragunathan is chairman and B Adi Reddy is the company secretary for Aurobindo Pharma Ltd.

    • PVRR P V Ramprasad Reddy Non-Exec & Non-Independent Dir
    • KNR K Nithyananda Reddy Vice Chairman & M.D.
    • MS M Sivakumaran Whole-time Director
    • MMMR M Madan Mohan Reddy Whole-time Director
    • PSCR P Sarath Chandra Reddy Director
    • KR K Ragunathan Chairman & Independent Directo
    • ABS Avnit Bimal Singh Non-Exec. & Independent Dir.
    • BAR B Adi Reddy Company Sec. & Compli. Officer
    • SM Savita Mahajan Non-Exec. & Independent Dir.
    • GPV Girish Paman Vanvari Non-Exec. & Independent Dir.
    • SM Santanu Mukherjee Independent Director

    Top Stories

    Thank you! Your transaction has been completed successfully.
    Sorry! Transaction failed. Please try again later.

    DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

    DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

    By using this website, you agree to the Terms of Service and Privacy Policy.